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Introduction
A number of terms were used to describe Castleman’s
disease, including angiofollicular or giant lymph node
hyperplasia, since Castleman and colleagues described
this entity in 1956 (1). Castleman et al. described this
disease as ‘hyaline vascular’ type but, in contrast, in 1969
Flendrig et al. and later in 1972 Keller et al. recognised
a different histological type, which is now referred to as
the ‘plasma cell’ type. But these two types were mani-
festations of the same disease because there were cases
with overlapping histological features (2, 3).
This entity is currently classified into two major sub-
groups: localized Castleman’s disease and multicentric
(disseminated) Castleman’s disease. There are also three
histologic variants: hyaline-vascular, plasma cell and tran-
sitional (mixed type) in English literature (4, 5).
The localized form, identified by Benjamin Castle-
man, usually presents in young adults with localized mas-
ses in the mediastinum (60-75%), neck (20%) or less
commonly intra-abdominal masses (10%). However
multicentric Castleman’s disease presents with poly -
lymphadenopathy and frequently multi-organ involve-
ment and is associated with systemic features. Multi-
centric Castleman’s diseases are less common than the
localized variant and while multicentric form follows a
more aggressive natural course, systemic symptoms are
rare in the localized form (6). The localized form is ty-
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pically the hyaline-vascular type and most multicentric
cases subsequently described have been of the plasma-
cell type (7).
We report three patients with Castleman’s disease ari-
sing in lymphoid tissue of the cervical region and un-
derwent total excision.
Patients and methods
We present 3 cases of Castleman’s disease localized in cervical
region that were treated in Diyarbakir Education and Research Ho-
spital between 2006-2009. Diagnosis were made by histopatholo-
gical examination. HIV, HHV-8, EBV and HBV viral loads were
studied by PCR method. Also IL-6 levels were measured by immu-
noassay method. The characteristics of three patients were showed
in Table 1.
Case 1
A 17-year-old female was admitted to our hospital. She had suf-
fered from neck swelling in the last one year. General physical exa-
mination revealed a mass, 3 cm of diameter, at posterior of the left
sterno-cleido-mastoid muscle (SCM). Laboratory studies and che-
st radiography found no abnormalities. Computed tomography (CT)
showed a mass, 41x20x25 mm in size, at posterolateral left SCM with
irregular borders (Fig. 1). The tumor was resected completely. In the
postoperative follow-up no local progression or recurrence or other
problems were observed. 
Case 2
A 27-year- old female patient presented with a 7- month history
of supraclavicular mass. Physical examination revealed no significant
abnormality except a firm, movable and non-tender mass measuring
3x4 cm in size, at posterior of the right SCM muscle. CT revealed
a well-defined mass (3.2x4.3x5.2 cm) at the posterior of the right
SCM muscle. Laboratory data and tumor markers were within the
normal limits. Chest X-ray was normal. Extensive resection was
performed. The mass was well capsulated and easily removed. The-
re has been no evidence of progression or recurrence after 18 months
of follow-up.
Case 3
A 23-year-old female patient was admitted to emergency unit
with complaint of painful right cervical mass for last 7-8 months.
Examination revealed a mass on the left SCM. CT imaging of the
neck showed a mass measuring 3.5x4.2x4 cm in diameter, which was
located behind left SCM. There were no specific deviations in the
biochemical results. Resection was performed. There was no local
recurrence in postoperative follow-up.
Pathology
Histopathological examination of the surgical specimens re-
vealed lymphoid mantles with germinal centers of varying sizes.
These germinal centers were penetrated by hyalinised venules. Al-
so the follicles were separated by hypervascular interfollicular tis-
sue. High power demonstrated that the single follicle was composed
entirely of concentratrically arranged small lymphocytes penetra-
ted by a number of small vessels. These histological findings are
consistent with a diagnosis of Castleman’s disease hyaline-vascu-
lar type (Fig. 2). 
TABLE 1 - CHARACTERISTICS OF PATIENTS WITH CASTLEMAN’S DISEASE.
Case 1 Case 2 Case 3
Age, yrs 17 27 23
Sex( M/F) F F F
Onset 12 months 7 months 8 months
IL-6 level (pg/ml) 19,4 10,3 4,1
EBV viral load Neg Neg Neg
HHV-8 viral load Neg Neg Neg
HBV viral load Neg Neg Neg
HIV viral load Neg Neg Neg
Pathological type Hyaline-vascular Hyaline-vascular Hyaline-vascular
Fig. 1 - The follicle consist of large, concentrically arranged mantle zone
lymphocytes surrounding atrophic germinal centers. The interfollicular areas
contain a network of small vessels (hematoxylin and eosin, 200x magnifi-
cation). 
Discussion
Castleman’s disease can be classified into three hi-
stopathological groups: hyaline-vascular type, with a good
prognosis, plasma-cellular and mixed types; the latter two
are both more aggressive than the hyaline-vascular type
(8). All of our cases were of hyalin-vascular type and re-
vealed very good prognosis. 
Males and females are affected equally and the age
is ranged from 8 to 66 years. Several immunological me-
chanisms have been proposed for the etiology including
overproduction of interleukin-6 and human herpes vi-
rus type 8 infection (3, 9). The HHV-8, EBV, HBV and
HIV viral loads were evaluated by PCR method. The-
re were no abnormality in the results. In patients quan-
titative analysis were made by using IL-6 kit in Immu-
lite-DPS® device by immunoassay method. Two of them
showed elevated IL–6 levels (normal range <5 pg/ml)
(10). 
However there is no consensus on the underlying etio-
logy of this entity but two main theories have been pro-
posed. One theory submits that the disorder represents
a reactive lymphoid hyperplasia initiated by chronic an-
tigenic stimulation associated with a viral trigger (whi-
ch remains undefined), most likely mediated through
the respiratory or gastrointestinal tract, the most com-
mon affected sites. The other theory proposes that the
masses are due to a developmental growth disturbance
of the lymphoid tissue, i.e. a vascular lymphoid ha-
martoma (11).
Two clinical types of this disease have already been
described, i.e. the localized or unifocal type and the mul-
ticentric or multifocal type. Traditionally the majority
of cases can be categorized as localized hyaline-vascular,
localized plasma cell or multicentric plasma cell. The pa-
tients presented here were diagnosed as localized Ca-
stleman’s disease of the hyaline-vasculare type. 
The localized hyaline-vascular type is often asymp-
tomatic or, as in our patients, there are symptoms cau-
sed by the mass effect of the lesion. This type is seen in
90% of the cases of localized disease (12). This form may
represent reactive lymphoid hyperplasia due to chronic
antigenic stimulation from viral infection (13). The other
10 % of the cases of localized disease is defined as the
localized plasma cell type. These patients present with
symptoms such as fever, fatigue, weight loss and labo-
ratory abnormalities. 
The multicentric type is a systemic disease with dis-
seminated lymphadenopathy, hepatosplenomegaly and
other symptoms (14). This type is a more aggressive form
with a potentially malignant profile in association, for
example, with polyneuropathy, organomegaly, endocri-
nopathy, monoclonal proteinemia and skin lesions,
Hodgkin’s disease, Kaposi’s sarcoma and acquired im-
munodeficiency syndrome (15).
The diagnosis of Castleman’s disease is ultimately ma-
de by histology, thereby requiring either removal or bio-
psy of the lesion. Histological examination of the lymph
node in the localized hyaline-vascular type shows small
hyaline vascular follicles with interfollicular capillary pro-
liferation. Histology of the affected lymph-nodes in the
localized plasma cell type shows large follicles with in-
tervening sheets of plasma cells. The multicentric type
is histologically similar to the localized plasma cell type
(14). 
There are some benign and malignant conditions, in-
cluding lymphoma and thymoma, which may appear hi-
stologically similar to Castleman’s disease. Therefore, im-
munohistologic and immunologic gene rearrangement
studies of the specimens can be useful in solidifying the
diagnosis. Identifying an immunophenotypically varied
population of B lymphocytes with polyclonal surface and
cytoplasmic immunoglobulin markers helps to confirm
the diagnosis of Castleman’s disease and to differentia-
te it from lymphoma (11). 
The most prominent sites are mediastinum 
(60-75%), neck (20%) or less commonly abdomen
(10%) and axilla (4%). Reviewing the literature, we
found only a few case reports of cervical Castleman’s di-
sease and most of them presented with a solitary neck
mass (16-18). Only Song et al. reported a series of Ca-
stleman’s disease that includes 12 patients (19).
The preoperative imaging of Castleman’s disease is
nonspecific. At CT scan, the lesions may present as a
homogenous or heterogenous soft tissue mass, and con-
trast enhancement depends on the injection rate and vo-
lume of contrast media. The differential diagnosis mu-
st include infectious and inflammatory lesions such as
337
Castleman’s disease as cervical mass: a report of three cases and review of the literature
Fig. 2 - A left giant cervical mass of lymphoid tissue (41x20x25 mm) with irre-
gular borders.
lymphadenitis, tuberculosis, sarcoidosis, toxoplasmosis,
cytomegalovirus, mononucleosis, HIV and cat scratch
disease (20).
The only diagnosis and curative treatment is the com-
plete surgical excision of the mass and the surrounding
nodes. All symptoms disappear after removal of the tu-
mour. No recurrences have been reported in the litera-
ture after complete resection of the hyaline-vascular ty-
pe. For patients who have incomplete or unresectable
lesions, radiotherapy has been used with limited effec-
tiveness. The unfortunate few case of the more aggres-
sive plasma cell variant often require treatment with ste-
roids and systemic chemotherapy.
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